arrow Log In to View Account     |      
HOME
Johns Hopkins Medicine
Hopkins Logo


|

Click below to register.

There are no fees to attend!


Saturday, December 7, 2019

8:00 AM – 8:30 AM: Registration and Breakfast
8:30 AM – 12:30 PM: Interactive CE Activity


Baltimore Marriott Waterfront
700 Aliceanna St
Baltimore, Maryland

OVERVIEW
Multiple sclerosis (MS) is a highly heterogeneous disease with regard to presenting symptoms, disease activity, relapse, and rate of disability progression. Although there is no cure for MS, a plethora of diverse current and emerging disease-modifying therapies aim to slow disease progression, reduce relapses, and limit disability. However, clinical uncertainties create questions regarding the diagnosis, treatment, and overall management of patients with MS. These questions include: How do we recognize symptoms and accurately diagnose MS? Which therapies should be used? When is the best time to initiate, switch, and/or discontinue treatment? How do we incorporate continuously emerging real-world data into treatment decision-making? How do we optimally manage symptoms while minimizing treatment side effects and improve a patient's health-related quality of life? How do we facilitate shared decision-making and patient-centered care?

This interactive live symposium series will bring together MS experts to present and discuss the latest criteria and methodologies involved in MS diagnosis, to evaluate the most recent clinical trial and real-world data on MS treatment strategies, and to optimize patient-centered management to improve outcomes for patients with MS. This program will include breakout sessions to discuss case studies from the perspectives of the neurologist, the MS specialty nurse, and the primary care provider.


GOAL
The goal of this program is to provide neurologists, primary care physicians, nurse practitioners, physician assistants, nurses and other healthcare providers who treat patients with MS with the latest science and clinical issues related to the management of patients with MS as well as the opportunity to discuss cases with local MS experts.

INTENDED AUDIENCE
This activity is intended for neurologists, primary care physicians, nurse practitioners, physician assistants, nurses, other healthcare providers who treat patients with MS, as well as patients and their caregivers. No prerequisites required.

STEERING COMMITTEE
Scott Newsome, DO, MSCS, FAAN
Associate Professor of Neurology
Director, Neurosciences Consultation and Infusion Center at Green Spring Station
Director, Stiff Person Syndrome Center
Member, Miller-Coulson Academy of Clinical Excellence
Johns Hopkins School of Medicine
Division of Neuroimmunology and Neuroinfectious Diseases
Baltimore, Maryland

Lisa Fox, PA-C, MS
Physicians’ Assistant, Department of Neurology
Division of Neuroimmunology and Neuroinfectious Diseases
Johns Hopkins Hospital
Baltimore, Maryland
Kathleen Costello, MS, CRNP, MSCN
Nurse Practitioner
Johns Hopkins Multiple Sclerosis Center
Associate Vice President Healthcare Access
National MS Society
Baltimore, Maryland

LOCAL FACULTY
Elias Sotirchos, MD
Neuroimmunology Fellow
Johns Hopkins School of Medicine
Baltimore, Maryland


LEARNING OBJECTIVES
After attending this activity, the participant will demonstrate the ability to:
  • ASSESS the most recent clinical and real word data on approved MS DMTs.
  • EVALUATE the most recent evidence-based data and potential clinical implications of new and emerging DMTS for relapsing and progressive MS.
  • RECOGNIZE the role of patient preferences, disease-specific factors, and shared decision-making in informing MS treatment and management.
  • APPLY up-to-date clinical knowledge to develop both practice-specific and interprofessional strategies to individualized MS management plans.
The Johns Hopkins School of Medicine and the Institute for Johns Hopkins Nursing take responsibility for the content, quality, and scientific integrity of this CME/CNE activity.


ACCREDITATION STATEMENTS
accme_logoThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Johns Hopkins School of Medicine and the Institute for Johns Hopkins Nursing. The Johns Hopkins School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

CREDIT DESIGNATION STATEMENTS
The Johns Hopkins School of Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This 4.0 contact hour educational activity is provided by the Institute for Johns Hopkins Nursing. Claim only those contact hours actually spent in the activity.

AGENDA
  • Registration and Breakfast

  • Welcome, Conference Goals, and Preassessment

  • Update on Multiple Sclerosis:
    Overview and Diagnosis with Expert Panel Discussion

    Local Faculty

  • Remaining Up-to-Date with the Evolving DMT Landscape in MS with Expert Panel Discussion
    Scott Newsome, DO, MSCS, FAAN

  • Symptom Management and Interprofessional Strategies to Individualize Treatment with Expert Panel Discussion
    Lisa Fox, PA-C, MS

  • Breakout Sessions

  • Breakout Session Debriefing

  • Final Remarks and Postassessment
This schedule is subject to change.


POLICY ON FACULTY AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins School of Medicine that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

It is the policy of the Institute for Johns Hopkins Nursing to require our continuing nursing education program faculty and planning committee members to disclose any financial relationships with companies providing program funding or manufacturers of any commercial products discussed in the program. Detailed disclosures will be made in the course materials.

AMERICANS WITH DISABILITIES ACT (ADA)
The Johns Hopkins School of Medicine and the Institute for Johns Hopkins Nursing fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

FEE INFORMATION
There is no fee for this educational activity.

Register Now!

Supported by educational grants from Biogen and EMD Serono.


<img src="http://www.jhasio1.com/asim/pictures/proceed_pretestASIM.png" alt="procced to pretest" border="0" />




Johns Hopkins Advanced Studies in Medicine (ISSN-1558-0334), is published by ASiM CE, LLC, d/b/a ASiM, PO Box 340, Somerville, NJ 08876. (908) 253-9001. Copyright ©2017 by ASiM CE, LLC. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. ASiM is a registered trademark of ASiM CE LLC.